Hadraoui Ghita, Berkich Samir, Iharti Rokkaya, Berkaoui Mohamed, Bounid Oumayma, Igarramen Tarik, M. Darfaoui, A. Omrani, M. Khouchani
{"title":"Cancer Stem Cells in Breast Cancer","authors":"Hadraoui Ghita, Berkich Samir, Iharti Rokkaya, Berkaoui Mohamed, Bounid Oumayma, Igarramen Tarik, M. Darfaoui, A. Omrani, M. Khouchani","doi":"10.36347/sjmcr.2024.v12i05.010","DOIUrl":null,"url":null,"abstract":"Breast cancer represents a real public health problem in Morocco with one of the highest rates of mortality. Cancer stem cells are a small subset of cells found in many types of malignancies, including breast cancer, they have a crucial role in carcinogenesis, progression, recurrences and therapeutic resistance. Our study aims to understand the characteristics of breast cancer stem cells that could explain the aggressive behavior of certain tumors, with an emphasis on CD326, as a biomarker for BCSC, hoping for new targeted therapies in the future.","PeriodicalId":21448,"journal":{"name":"Scholars Journal of Medical Case Reports","volume":" 23","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scholars Journal of Medical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36347/sjmcr.2024.v12i05.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Breast cancer represents a real public health problem in Morocco with one of the highest rates of mortality. Cancer stem cells are a small subset of cells found in many types of malignancies, including breast cancer, they have a crucial role in carcinogenesis, progression, recurrences and therapeutic resistance. Our study aims to understand the characteristics of breast cancer stem cells that could explain the aggressive behavior of certain tumors, with an emphasis on CD326, as a biomarker for BCSC, hoping for new targeted therapies in the future.